Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 15, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 18, 2026
OfficerIndirect holdingOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001673232-26-000013
Filed / recorded
Mar 18, 2026, 1:10 AM UTC
Added to OQRO
Oct 6, 2026, 9:34 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
UNITED THERAPEUTICS Corp
Issuer CIK
1082554
Ticker
UTHR
Reporting person
Michael Benkowitz
Relationship
Officer
Officer title
PRESIDENT AND COO
Security
Restricted Stock Units
Table
Derivative (Table II)
Transaction date
Mar 15, 2026
Transaction code
M
Shares / units
17,790
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
0
Ownership form
Indirect — by Trust
Amendment
No
Footnotes from the filing
Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
Shares received upon vesting of performance-based restricted stock units on March 15, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These restricted stock units were granted on March 15, 2023.
Securities held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power.